These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 32023603)
1. [Enhancer hijacking via disease-specific chromosomal translocation in blastic plasmacytoid dendritic cell neoplasm]. Kubota S Rinsho Ketsueki; 2020; 61(1):47-51. PubMed ID: 32023603 [TBL] [Abstract][Full Text] [Related]
2. Blastic plasmacytoid dendritic cell neoplasm with genetic mutations in multiple epigenetic modifiers: a case report. Dang X; Zhou D; Meng L; Bi L J Int Med Res; 2021 Feb; 49(2):300060520982667. PubMed ID: 33530792 [TBL] [Abstract][Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity. Lim MS; Lemmert K; Enjeti A BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132 [TBL] [Abstract][Full Text] [Related]
4. Blastic Plasmacytoid Dendritic Cell Neoplasm, from a Dermatological Point of View. Di Raimondo C; Lozzi F; Di Domenico PP; Paganini C; Campione E; Galluzzo M; Bianchi L Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000208 [TBL] [Abstract][Full Text] [Related]
5. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy. Riaz W; Zhang L; Horna P; Sokol L Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive metagenomic analysis of blastic plasmacytoid dendritic cell neoplasm. Nomburg J; Bullman S; Chung SS; Togami K; Walker MA; Griffin GK; Morgan EA; LeBoeuf NR; DeCaprio JA; Meyerson M; Lane AA Blood Adv; 2020 Mar; 4(6):1006-1011. PubMed ID: 32182365 [TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerations. Pemmaraju N; Madanat YF; Rizzieri D; Fazal S; Rampal R; Mannis G; Wang ES; Foran J; Lane AA Leuk Lymphoma; 2024 May; 65(5):548-559. PubMed ID: 38391126 [TBL] [Abstract][Full Text] [Related]
8. [Blastic plasmacytoid dendritic cell tumor treated with DVT regimen: a case report and literature review]. Shi J; Xu N; Niu Y; Jia SX; Yang CM; Fang MY Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):86-89. PubMed ID: 38527844 [TBL] [Abstract][Full Text] [Related]
9. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm. Zhang X; Sun J; Yang M; Wang L; Jin J Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682 [TBL] [Abstract][Full Text] [Related]
10. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): A promising future in the era of targeted therapeutics. Adimora IJ; Wilson NR; Pemmaraju N Cancer; 2022 Aug; 128(16):3019-3026. PubMed ID: 35726525 [TBL] [Abstract][Full Text] [Related]
11. Diagnosis, treatment, and genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A review. Wang Y; Xiao L; Yin L; Zhou L; Deng Y; Deng H Medicine (Baltimore); 2023 Feb; 102(7):e32904. PubMed ID: 36800625 [TBL] [Abstract][Full Text] [Related]
12. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia. Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444 [TBL] [Abstract][Full Text] [Related]
13. Early T-cell precursor lymphoblastic leukemia accompanied by prominent blastic plasmacytoid dendritic cell proliferation mimicking blastic plasmacytoid dendritic cell neoplasm: an exceptional case report and literature review. Liao H; Yu J; Liu Y; Zhao S; Zhu H; Xu D; Jiang N; Zheng Q J Cancer Res Clin Oncol; 2022 Oct; 148(10):2911-2919. PubMed ID: 35933443 [TBL] [Abstract][Full Text] [Related]
14. Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics. Sapienza MR; Pileri S Hematol Oncol Clin North Am; 2020 Jun; 34(3):511-521. PubMed ID: 32336416 [TBL] [Abstract][Full Text] [Related]
15. Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms. Small C; Mukerjee S; Jangam D; Gollapudi S; Singh K; Jaye DL; Aung PP; Querfeld C; Yao K; Chisholm KM; Pullarkat S; Wang S; Gru A; Hussaini M; George TI; Ohgami RS Int J Lab Hematol; 2023 Oct; 45(5):726-734. PubMed ID: 37282364 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Biology and CD123-Directed Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm. Pemmaraju N; Deconinck E; Mehta P; Walker I; Herling M; Garnache-Ottou F; Gabarin N; Campbell CJV; Duell J; Moshe Y; Mughal T; Mohty M; Angelucci E Clin Lymphoma Myeloma Leuk; 2024 Apr; 24(4):e130-e137. PubMed ID: 38267355 [TBL] [Abstract][Full Text] [Related]
17. Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Pemmaraju N; Gupta V; Thompson MA; Lane AA Curr Hematol Malig Rep; 2016 Dec; 11(6):462-467. PubMed ID: 27492117 [TBL] [Abstract][Full Text] [Related]
18. Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm. Ashok Kumar P; Ombada M; Pemmasani G; Tambe A; Banki K; Gentile T J Investig Med High Impact Case Rep; 2022; 10():23247096221127114. PubMed ID: 36341907 [TBL] [Abstract][Full Text] [Related]